SG Stock MarketDetailed Quotes

IX Biopharma (42C)

Watchlist
  • 0.355
  • -0.010-2.74%
10min DelayNot Open May 19 17:15 CST
373.07MMarket Cap0.57P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

42C IX Biopharma

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2026
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(Q2)Dec 31, 2019
Operating cash flow (Indirect Method)
Cash from operating activities
-225.14%-2.87M
36.36%-4.46M
-794K
-883K
14.64%-7M
-439.47%-8.21M
126.61%2.42M
0.69%-9.08M
35.09%-9.15M
12.01%-2.54M
Net profit before non-cash adjustment
58.23%-916K
6.05%-10.14M
---1.7M
---2.19M
-12.26%-10.79M
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
-251.02%-10.5M
32.82%-2.42M
Total adjustment of non-cash items
-217.05%-721K
30.28%4.76M
--928K
--616K
96.19%3.65M
-75.86%1.86M
1,580.42%7.71M
-147.71%-521K
115.15%1.09M
-94.44%56K
-Depreciation and amortization
-20.87%182K
-1.61%854K
--189K
--230K
-6.57%868K
-12.36%929K
0.57%1.06M
0.48%1.05M
-13.80%1.05M
-30.67%260K
-Reversal of impairment losses recognized in profit and loss
--58K
-53.37%76K
--40K
--0
58.25%163K
-45.50%103K
8.00%189K
212.50%175K
194.74%56K
----
-Assets reserve and write-off
127.27%3K
-89.71%14K
--3K
---11K
615.79%136K
-9.52%19K
-22.22%21K
3.85%27K
-61.19%26K
-25.00%3K
-Disposal profit
--0
-85.33%392K
--107K
--104K
253.39%2.67M
-153.45%-1.74M
81,575.00%3.26M
-500.00%-4K
100.01%1K
--0
-Net exchange gains and losses
-5,426.32%-1.05M
6,738.00%3.32M
--701K
---19K
-101.91%-50K
45.53%2.62M
205.44%1.8M
-427.16%-1.71M
-124.14%-324K
-163.10%-313K
-Remuneration paid in stock
--0
103.79%32K
--1K
--2K
-198.60%-845K
-37.94%857K
38.52%1.38M
85.32%997K
-24.01%538K
-35.92%182K
-Deferred income tax
-131.90%-74K
-177.00%-231K
---218K
--232K
125.23%300K
-494.50%-1.19M
83.73%-200K
-203.46%-1.23M
-60.71%-405K
30.52%-107K
-Other non-cash items
105.13%160K
-25.92%303K
--105K
--78K
54.92%409K
30.69%264K
20.96%202K
10.60%167K
287.18%151K
1,450.00%31K
Changes in working capital
-277.81%-1.23M
575.18%925K
---24K
--694K
130.31%137K
35.24%-452K
-112.80%-698K
-225.67%-328K
106.71%261K
39.46%-178K
-Change in receivables
-405.56%-385K
173.15%79K
--38K
--126K
87.26%-108K
-263.95%-848K
-1,394.44%-233K
107.83%18K
-641.94%-230K
-1,980.00%-94K
-Change in inventory
-170.00%-162K
149.51%305K
--96K
---60K
-204.95%-616K
-359.09%-202K
87.36%-44K
-319.28%-348K
77.51%-83K
96.94%-6K
-Change in payables
-199.11%-556K
-44.07%481K
---25K
--561K
20.62%860K
368.05%713K
-274.65%-266K
-114.00%-71K
114.82%507K
-1.69%-120K
-Changes in other current assets
-295.52%-131K
5,900.00%60K
---133K
--67K
100.87%1K
25.81%-115K
-312.33%-155K
8.96%73K
198.53%67K
180.00%42K
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
16.67%-10K
11.67%-53K
-14K
-12K
-60K
0
Interest received (cash flow from operating activities)
4K
-45.45%18K
0
0
371.43%33K
7K
0
-91.95%7K
-53.97%87K
1,000.00%22K
Tax refund paid
-28.57%-54K
53.56%734K
-44K
-42K
-11.15%478K
-23.80%538K
-2.49%706K
-2.03%724K
739K
0
Other operating cash inflow (outflow)
0
0
0
0
0
0
0
0
0
0
Operating cash flow
-212.81%-2.93M
42.65%-3.76M
---852K
---937K
14.45%-6.55M
-345.28%-7.66M
137.39%3.12M
-0.38%-8.35M
40.15%-8.32M
12.71%-2.52M
Investing cash flow
Net PPE purchase and sale
25.71%-26K
26.64%-201K
---44K
---35K
60.58%-274K
-247.50%-695K
60.55%-200K
48.48%-507K
35.85%-984K
73.21%-217K
Net intangibles purchase and sale
----
--0
----
----
---11K
--0
----
----
93.51%-10K
---10K
Net investment product transactions
----
--0
----
----
--1.34M
--0
---5.42M
--0
----
----
Investing cash flow
25.71%-26K
-119.03%-201K
---44K
---35K
251.94%1.06M
87.64%-695K
-1,009.07%-5.62M
48.99%-507K
-110.20%-994K
71.98%-227K
Financing cash flow
Net issuance payments of debt
-490.91%-774K
-37.16%915K
--1.05M
--198K
341.06%1.46M
-180.64%-604K
431.42%749K
-6.10%-226K
62.30%-213K
-84.42%-142K
Net common stock issuance
--14.69M
--3.25M
--0
--0
--0
-71.65%2.73M
-5.53%9.62M
--10.18M
----
----
Increase or decrease of lease financing
29.77%-92K
-1.57%-453K
---89K
---131K
-14.95%-446K
-3.47%-388K
0.79%-375K
-0.80%-378K
---375K
----
Interest paid (cash flow from financing activities)
-180.00%-154K
-139.16%-629K
---294K
---55K
2.95%-263K
-34.16%-271K
-16.09%-202K
26.89%-174K
4.42%-238K
13.64%-57K
Net other fund-raising expenses
----
256.52%36K
--0
--0
42.50%-23K
---40K
----
--622K
----
----
Financing cash flow
113,825.00%13.67M
330.80%3.12M
--662K
--12K
-49.12%724K
-85.46%1.42M
-2.34%9.79M
1,313.56%10.02M
47.62%-826K
-177.43%-199K
Net cash flow
Beginning cash position
242.76%5.21M
-80.53%1.15M
--564K
--1.52M
-54.08%5.93M
131.08%12.91M
24.94%5.59M
-69.61%4.47M
-28.83%14.71M
-15.24%12.58M
Current changes in cash
1,216.04%10.71M
82.40%-840K
---234K
---960K
31.15%-4.77M
-195.10%-6.93M
525.67%7.29M
111.49%1.17M
-76.84%-10.14M
14.36%-2.95M
Effect of exchange rate changes
-300.00%-8K
--12K
---4K
--4K
--0
-246.88%-47K
164.00%32K
49.49%-50K
55.61%-99K
68.29%-13K
End cash Position
2,721.99%15.92M
-71.75%326K
--326K
--564K
-80.53%1.15M
-54.08%5.93M
131.08%12.91M
24.94%5.59M
-69.61%4.47M
-15.31%9.62M
Free cash flow
-204.22%-2.96M
42.10%-3.96M
---896K
---972K
18.16%-6.84M
-385.84%-8.36M
132.82%2.92M
4.39%-8.91M
40.25%-9.31M
25.70%-2.75M
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
(Q3)Mar 31, 2026(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(Q2)Dec 31, 2019
Operating cash flow (Indirect Method)
Cash from operating activities -225.14%-2.87M36.36%-4.46M-794K-883K14.64%-7M-439.47%-8.21M126.61%2.42M0.69%-9.08M35.09%-9.15M12.01%-2.54M
Net profit before non-cash adjustment 58.23%-916K6.05%-10.14M---1.7M---2.19M-12.26%-10.79M-109.11%-9.62M44.16%-4.6M21.57%-8.23M-251.02%-10.5M32.82%-2.42M
Total adjustment of non-cash items -217.05%-721K30.28%4.76M--928K--616K96.19%3.65M-75.86%1.86M1,580.42%7.71M-147.71%-521K115.15%1.09M-94.44%56K
-Depreciation and amortization -20.87%182K-1.61%854K--189K--230K-6.57%868K-12.36%929K0.57%1.06M0.48%1.05M-13.80%1.05M-30.67%260K
-Reversal of impairment losses recognized in profit and loss --58K-53.37%76K--40K--058.25%163K-45.50%103K8.00%189K212.50%175K194.74%56K----
-Assets reserve and write-off 127.27%3K-89.71%14K--3K---11K615.79%136K-9.52%19K-22.22%21K3.85%27K-61.19%26K-25.00%3K
-Disposal profit --0-85.33%392K--107K--104K253.39%2.67M-153.45%-1.74M81,575.00%3.26M-500.00%-4K100.01%1K--0
-Net exchange gains and losses -5,426.32%-1.05M6,738.00%3.32M--701K---19K-101.91%-50K45.53%2.62M205.44%1.8M-427.16%-1.71M-124.14%-324K-163.10%-313K
-Remuneration paid in stock --0103.79%32K--1K--2K-198.60%-845K-37.94%857K38.52%1.38M85.32%997K-24.01%538K-35.92%182K
-Deferred income tax -131.90%-74K-177.00%-231K---218K--232K125.23%300K-494.50%-1.19M83.73%-200K-203.46%-1.23M-60.71%-405K30.52%-107K
-Other non-cash items 105.13%160K-25.92%303K--105K--78K54.92%409K30.69%264K20.96%202K10.60%167K287.18%151K1,450.00%31K
Changes in working capital -277.81%-1.23M575.18%925K---24K--694K130.31%137K35.24%-452K-112.80%-698K-225.67%-328K106.71%261K39.46%-178K
-Change in receivables -405.56%-385K173.15%79K--38K--126K87.26%-108K-263.95%-848K-1,394.44%-233K107.83%18K-641.94%-230K-1,980.00%-94K
-Change in inventory -170.00%-162K149.51%305K--96K---60K-204.95%-616K-359.09%-202K87.36%-44K-319.28%-348K77.51%-83K96.94%-6K
-Change in payables -199.11%-556K-44.07%481K---25K--561K20.62%860K368.05%713K-274.65%-266K-114.00%-71K114.82%507K-1.69%-120K
-Changes in other current assets -295.52%-131K5,900.00%60K---133K--67K100.87%1K25.81%-115K-312.33%-155K8.96%73K198.53%67K180.00%42K
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities) 16.67%-10K11.67%-53K-14K-12K-60K0
Interest received (cash flow from operating activities) 4K-45.45%18K00371.43%33K7K0-91.95%7K-53.97%87K1,000.00%22K
Tax refund paid -28.57%-54K53.56%734K-44K-42K-11.15%478K-23.80%538K-2.49%706K-2.03%724K739K0
Other operating cash inflow (outflow) 0000000000
Operating cash flow -212.81%-2.93M42.65%-3.76M---852K---937K14.45%-6.55M-345.28%-7.66M137.39%3.12M-0.38%-8.35M40.15%-8.32M12.71%-2.52M
Investing cash flow
Net PPE purchase and sale 25.71%-26K26.64%-201K---44K---35K60.58%-274K-247.50%-695K60.55%-200K48.48%-507K35.85%-984K73.21%-217K
Net intangibles purchase and sale ------0-----------11K--0--------93.51%-10K---10K
Net investment product transactions ------0----------1.34M--0---5.42M--0--------
Investing cash flow 25.71%-26K-119.03%-201K---44K---35K251.94%1.06M87.64%-695K-1,009.07%-5.62M48.99%-507K-110.20%-994K71.98%-227K
Financing cash flow
Net issuance payments of debt -490.91%-774K-37.16%915K--1.05M--198K341.06%1.46M-180.64%-604K431.42%749K-6.10%-226K62.30%-213K-84.42%-142K
Net common stock issuance --14.69M--3.25M--0--0--0-71.65%2.73M-5.53%9.62M--10.18M--------
Increase or decrease of lease financing 29.77%-92K-1.57%-453K---89K---131K-14.95%-446K-3.47%-388K0.79%-375K-0.80%-378K---375K----
Interest paid (cash flow from financing activities) -180.00%-154K-139.16%-629K---294K---55K2.95%-263K-34.16%-271K-16.09%-202K26.89%-174K4.42%-238K13.64%-57K
Net other fund-raising expenses ----256.52%36K--0--042.50%-23K---40K------622K--------
Financing cash flow 113,825.00%13.67M330.80%3.12M--662K--12K-49.12%724K-85.46%1.42M-2.34%9.79M1,313.56%10.02M47.62%-826K-177.43%-199K
Net cash flow
Beginning cash position 242.76%5.21M-80.53%1.15M--564K--1.52M-54.08%5.93M131.08%12.91M24.94%5.59M-69.61%4.47M-28.83%14.71M-15.24%12.58M
Current changes in cash 1,216.04%10.71M82.40%-840K---234K---960K31.15%-4.77M-195.10%-6.93M525.67%7.29M111.49%1.17M-76.84%-10.14M14.36%-2.95M
Effect of exchange rate changes -300.00%-8K--12K---4K--4K--0-246.88%-47K164.00%32K49.49%-50K55.61%-99K68.29%-13K
End cash Position 2,721.99%15.92M-71.75%326K--326K--564K-80.53%1.15M-54.08%5.93M131.08%12.91M24.94%5.59M-69.61%4.47M-15.31%9.62M
Free cash flow -204.22%-2.96M42.10%-3.96M---896K---972K18.16%-6.84M-385.84%-8.36M132.82%2.92M4.39%-8.91M40.25%-9.31M25.70%-2.75M
Currency Unit SGDSGDSGDSGDSGDSGDSGDSGDSGDSGD
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.54%
Sample Name
Sample Code
 +4.71%
Sample Name
Sample Code
 0.00%
4
SHANGHAI PECHEM
00338
-0.81%
5
SINOPEC CORP
00386
-0.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +42.01%
Sample Name
Sample Code
 +32.82%
Sample Name
Sample Code
 +26.86%
4
Emdoor Information
001314
+25.83%
5
Digital China Group
000034
+20.88%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19 Eastern Time, Trump warned that Iran might only have a negotiating window until Sunday or early next week, adding that 'it may be Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -